FOR IMMEDIATE RELEASE 11 November 2004
SOPHEON PLC
Additional Listing
Sopheon plc announces that it has issued 4,166,667 ordinary shares of 5p each
in connection with the exercise of conversion rights in respect of £500,000
nominal value of convertible loan stock, at a conversion price of 12p per
ordinary share. As described in Sopheon's announcement of 25 June 2004, the
terms of the loan stock, of which approximately £1.5m now remains unconverted,
were recently modified such that it no longer carries an interest coupon, and
such that any unconverted loan stock will automatically convert into equity at
maturity on 31 December 2005. Application has been made for the new ordinary
shares to be admitted to trading on AIM and dealings are expected to commence
on 16 November 2004.
For further information contact:
Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685
735
Arif Karimjee, CFO
Adam Reynolds Hansard Communications Tel : + 44 (0) 207 245
1100
Andrew Tan
+ 44 (0) 7957 203 685
Barbara Jansen Citigate First Financial Tel : + 31 (0) 205 754
010
1
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.